BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12453086)

  • 1. Mycophenolate in treatment-resistant inflammatory neuropathies.
    Umapathi T; Hughes R
    Eur J Neurol; 2002 Nov; 9(6):683-5. PubMed ID: 12453086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study.
    Radziwill AJ; Schweikert K; Kuntzer T; Fuhr P; Steck AJ
    Eur Neurol; 2006; 56(1):37-8. PubMed ID: 16914929
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy.
    Gorson KC; Amato AA; Ropper AH
    Neurology; 2004 Aug; 63(4):715-7. PubMed ID: 15326250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil in dysimmune neuropathies: a preliminary study.
    Benedetti L; Grandis M; Nobbio L; Beronio A; Ghiglione E; Manzino M; Primavera A; Mancardi G; Schenone A
    Muscle Nerve; 2004 May; 29(5):748-9. PubMed ID: 15116381
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
    Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
    Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory demyelinating polyradiculoneuropathy, in an 8-year-old girl, complicated by deafness and kidney fibrosis.
    Stojanovic VD; Doronjski AR; Spasojevic SD; Pavlovic VS; Nikolic MM; Kovacevic BB
    J Child Neurol; 2009 Aug; 24(8):997-1000. PubMed ID: 19240045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Swan AV; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2010 Nov; (11):CD003280. PubMed ID: 21069674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of multifocal acquired demyelinating sensory and motor neuropathy with whole body alopecia].
    Machino Y; Nakayama S; Tomimoto H
    Rinsho Shinkeigaku; 2014; 54(6):507-10. PubMed ID: 24990836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.
    Umapathi T; Hughes RA; Nobile-Orazio E; Léger JM
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003217. PubMed ID: 16034892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory chronic inflammatory demyelinating polyneuropathy with interferon beta 1B.
    Cocco E; Mamusa E; Carboni N; Marrosu G; Vannelli A; Mascia MG; Sirca A; Marrosu MG
    J Neurol; 2005 Nov; 252(11):1420-2. PubMed ID: 15944862
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?
    Cocito D; Merola A; Romagnolo A; Peci E; Toscano A; Mazzeo A; Gentile L; Russo M; Fazio R; Filosto M; Siciliano G; Schirinzi E; Nobile-Orazio E; Lopiano L
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):791-3. PubMed ID: 26109674
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.
    Piepers S; Van den Berg-Vos R; Van der Pol WL; Franssen H; Wokke J; Van den Berg L
    Brain; 2007 Aug; 130(Pt 8):2004-10. PubMed ID: 17626040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 15. Nerve ultrasound improves detection of treatment-responsive chronic inflammatory neuropathies.
    Herraets IJT; Goedee HS; Telleman JA; van Eijk RPA; van Asseldonk JT; Visser LH; van den Berg LH; van der Pol WL
    Neurology; 2020 Apr; 94(14):e1470-e1479. PubMed ID: 31959710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon beta-1a in chronic inflammatory demyelinating polyneuropathy: case report.
    Villa AM; Garcea O; Di Egidio M; Saizar R; Sica RE
    Arq Neuropsiquiatr; 2004 Sep; 62(3B):892-4. PubMed ID: 15476092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2003; (1):CD003280. PubMed ID: 12535467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA
    Drugs; 2003; 63(3):275-87. PubMed ID: 12534332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.